Stockscreener 앱 받기
5.91
4.83%
-0.30
시간 외 거래:
6.00
0.09
+1.52%
전일 마감가:
$6.21
열려 있는:
$6.23
하루 거래량:
2.58M
Relative Volume:
0.84
시가총액:
$721.04M
수익:
$58.36M
순이익/손실:
$-25.72M
주가수익비율:
-16.23
EPS:
-0.3641
순현금흐름:
$-24.91M
1주 성능:
-10.73%
1개월 성능:
+9.65%
6개월 성능:
+72.81%
1년 성능:
+63.71%
1일 변동 폭
$5.87
$6.23
1주일 범위
$5.87
$6.65
52주 변동 폭
$2.12
$7.55
Aquestive Therapeutics Inc Stock (AQST) Company Profile
명칭
Aquestive Therapeutics Inc
전화
908-941-1900
주소
30 TECHNOLOGY DRIVE, WARREN, NJ
AQST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
5.91 | 757.64M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
120.98 | 52.29B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.61 | 45.27B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 42.39B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.13 | 34.18B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
500.30 | 21.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-10 | 개시 | Leerink Partners | Outperform |
| 2024-04-11 | 개시 | Piper Sandler | Overweight |
| 2024-03-28 | 개시 | Raymond James | Outperform |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2019-04-22 | 개시 | H.C. Wainwright | Buy |
| 2019-01-03 | 개시 | Lake Street | Buy |
| 2018-08-20 | 개시 | JMP Securities | Mkt Outperform |
| 2018-08-20 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Aquestive Therapeutics Inc 주식(AQST)의 최신 뉴스
Aquestive Therapeutics (NASDAQ:AQST) Trading Down 4.6%What's Next? - MarketBeat
Is Aquestive Therapeutics Stock Built to Withstand a Pullback? - Trefis
Pale Fire Capital SE Acquires 340,767 Shares of Aquestive Therapeutics, Inc. $AQST - MarketBeat
Looking at the Narrative for Aquestive Therapeutics After New Anaphylm Patents and FDA Momentum - Yahoo Finance
Aquestive Therapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Published on: 2025-12-08 02:09:31 - BỘ NỘI VỤ
Diametric Capital LP Acquires Shares of 165,373 Aquestive Therapeutics, Inc. $AQST - MarketBeat
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
What analyst consensus says on Aquestive Therapeutics Inc. stockJuly 2025 Intraday Action & Daily Profit Focused Screening - Newser
VP Cioffi Surrenders 2,083 Of Aquestive Therapeutics Inc [AQST] - TradingView
Sio Capital Management LLC Buys 555,860 Shares of Aquestive Therapeutics, Inc. $AQST - MarketBeat
Published on: 2025-12-03 04:52:42 - Newser
Aquestive Therapeutics (AQST) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Everstar Asset Management LLC Raises Holdings in Aquestive Therapeutics, Inc. $AQST - MarketBeat
Quarterly Trades: Why Aquestive Therapeutics Inc. stock could see breakout soon - BỘ NỘI VỤ
Returns Recap: Why Aquestive Therapeutics Inc. stock could see breakout soonPrice Action & Capital Efficiency Focused Ideas - moha.gov.vn
What technical charts say about Aquestive Therapeutics Inc. stockWeekly Investment Summary & Weekly Stock Breakout Alerts - BỘ NỘI VỤ
Aquestive Therapeutics (NASDAQ:AQST) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Aquestive’s Anaphylm Shows Positive Results in First Study in Kids - Allergic Living
Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
How Recent Regulatory Wins Are Shaping the Narrative for Aquestive Therapeutics - Yahoo Finance
Aquestive Therapeutics Shares Rise After $75 Million Funding Deal - MSN
Why Aquestive Therapeutics Inc. stock is favored by top institutionsTrade Volume Summary & Advanced Technical Analysis Signals - newser.com
How to monitor Aquestive Therapeutics Inc. with trend dashboardsEarnings Risk Report & High Return Stock Watch Alerts - newser.com
Can Aquestive Therapeutics Inc. stock sustain revenue growthPortfolio Profit Report & Real-Time Volume Trigger Notifications - newser.com
Why Aquestive Therapeutics Inc. stock is trending among retail tradersMarket Performance Summary & Proven Capital Preservation Tips - newser.com
Why Aquestive Therapeutics Inc. stock could outperform in 2025July 2025 Opening Moves & Technical Buy Zone Confirmations - newser.com
Aquestive Therapeutics (AQST) Price Target Increased by 14.80% to 10.51 - MSN
Aquestive Therapeutics Inc. stock momentum explainedMarket Rally & High Accuracy Trade Signal Alerts - newser.com
Risk vs reward if holding onto Aquestive Therapeutics Inc.Swing Trade & Real-Time Market Sentiment Reports - newser.com
Aquestive Therapeutics (NASDAQ:AQST) Trading Up 6.5%Here's Why - MarketBeat
Officer Kraus Files To Sell 53,100 Of Aquestive Therapeutics Inc [AQST] - TradingView
Will Aquestive Therapeutics Inc. bounce back from current supportLayoff News & AI Based Buy and Sell Signals - newser.com
Can trapped investors hope for a rebound in Aquestive Therapeutics Inc.Analyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Predicting Aquestive Therapeutics Inc. trend using moving averagesJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Aquestive Therapeutics’ Earnings Call: Optimism Amid Challenges - MSN
Aquestive Therapeutics (NASDAQ:AQST) Updates Amid Dow Jones Industrial Average - Kalkine Media
Why Aquestive Therapeutics Inc. stock is favored by pension fundsPortfolio Growth Summary & Real-Time Market Trend Scan - newser.com
Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) Stock Retreats 27% But Revenues Haven't Escaped The Attention Of Investors - simplywall.st
Aquestive Therapeutics Inc (AQST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aquestive Therapeutics Inc 주식 (AQST) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Jung Cassie | Chief Operating Officer |
Oct 15 '25 |
Option Exercise |
3.10 |
25,000 |
77,568 |
308,346 |
| Jung Cassie | Chief Operating Officer |
Oct 15 '25 |
Sale |
7.01 |
67,575 |
473,701 |
240,771 |
| Kraus Carl N | Chief Medical Officer |
Oct 15 '25 |
Sale |
7.00 |
20,272 |
141,904 |
282,475 |
| Boyd Peter E. | See Remarks |
Oct 15 '25 |
Sale |
7.00 |
10,000 |
70,000 |
268,323 |
3.98%
자본화:
|
볼륨(24시간):